Ozurdex 0.7 MG implants
Ended Awarded
- Contract number
- SPE2DX25F5ZZF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $6,032
Award facts
- Contract value 100% obligated
- $6,032.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $6,032.28 for OZURDEX 0.7 mg implants on June 18, 2025, with an ultimate completion date of July 11, 2025. The award was issued by the Defense Logistics Agency's Medical Supply Chain organization without a set-aside designation. This delivery order represents a continuation of supply services under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at $499,999,999 through November 2026, which authorizes the agency to issue firm fixed-price orders for pharmaceutical products supporting military health facilities worldwide.
OZURDEX is an FDA-approved corticosteroid implant used in ophthalmology to treat inflammatory conditions of the eye. Under this delivery order, DMS Pharmaceutical Group will supply the specified quantity of these medical implants to support the Department of Defense's healthcare operations. The company's role as a crucial supplier in the federal pharmaceutical supply chain is well-established, with a demonstrated track record of delivering branded and generic prescription drugs, biologics, and specialized medical consumables to military and federal healthcare facilities across the nation.
Quick answers
Who was awarded contract SPE2DX25F5ZZF?
SPE2DX25F5ZZF was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 18, 2025.
How much is contract SPE2DX25F5ZZF worth?
The government has obligated $6,032 on SPE2DX25F5ZZF.
Is contract SPE2DX25F5ZZF an order under another contract?
Yes. SPE2DX25F5ZZF is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F5ZZF competed?
The extent of competition for SPE2DX25F5ZZF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award